Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) – Stock analysts at Wedbush lowered their Q2 2023 earnings per share (EPS) estimates for shares of United Therapeutics in a research note issued to investors on Thursday, May 4th. Wedbush analyst A. Argyrides now forecasts that the biotechnology company will post earnings per share of $4.50 for […]
Premier Fund Managers Ltd bought a new position in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,000 shares of the biotechnology company’s stock, valued at approximately $6,617,000. Other institutional investors and hedge funds […]
Envestnet Asset Management Inc. grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 16.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,548 shares of the biotechnology company’s stock after purchasing an additional 8,327 shares during the period. Envestnet […]
StockNews.com upgraded shares of United Therapeutics (NASDAQ:UTHR – Get Rating) from a buy rating to a strong-buy rating in a report published on Thursday morning. UTHR has been the topic of several other research reports. Morgan Stanley decreased their price target on United Therapeutics from $320.00 to $316.00 and set an overweight rating on the […]
StockNews.com upgraded shares of United Therapeutics (NASDAQ:UTHR – Get Rating) from a buy rating to a strong-buy rating in a research report released on Thursday. A number of other equities analysts have also issued reports on the stock. LADENBURG THALM/SH SH lowered their target price on shares of United Therapeutics from $285.00 to $256.00 in […]